I will support legislation to lower the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs by establishing a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status.

John R. Curtis · Utah · Republican

policy impact 5.00 specificity 1.00 extraction confidence 97%

Contest this claim

Occurrences

Senators Curtis and Rosen introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine.

Curtis introduced legislation to reduce costs of prescription drugs and medical devices, prevent shortages, boost domestic production and jobs, and grant nonprofit manufacturers tax-exempt status.

Press Releases - Senator John Curtis
primary · press_release · model gpt-4.1

"Utahns and their families look to Congress to help cut red tape and streamline innovation, and alongside Senator Rosen, this legislation will help secure the domestic supply chain and empower nonprofit manufacturers to improve our most vulnerable health care markets."

Curtis backs the bipartisan bill to lower prescription drug and medical device costs, reduce shortages, strengthen domestic production, and support nonprofit manufacturers.

Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices - Senator John Curtis
primary · press_release · model gpt-5.4-mini

Evidence

The member page lists S.3325, "Expanding Access to Affordable Drugs and Medical Devices Act," with latest action "Senate - 12/03/2025 Read twice and referred to the Committee on Finance."

Official congressional record shows the bill was introduced and referred, with no later action shown on the member page through the current review date; the commitment remains unresolved.

unresolved same_term

John R. Curtis | Congress.gov | Library of Congress
secondary · model gpt-5.4-mini · confidence 96%

Contest this evidence item

The press release says Senators Rosen and Curtis introduced a bipartisan bill that would "create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status" and lower costs of prescription drugs and medical devices.

This confirms concrete legislative effort consistent with the promise, but it is introduction-stage activity rather than delivery; there is no evidence in the lookback window of enactment, committee advancement, or executive implementation.

partial same_term A for effort

Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices - Senator John Curtis
primary · model gpt-5.4-mini · confidence 92%

Contest this evidence item

Assessments

delivered same_term

Curtis made the promised federal legislative support action during his Senate term by introducing bipartisan legislation with Senator Rosen to create a clear tax-exempt pathway for nonprofit drug and medical device manufacturers, matching the mechanism described in the promise. The bill had only been introduced and referred, so the broader policy outcome was not enacted, but the promise was framed as supporting legislation rather than guaranteeing passage.

provider codex_cli · model gpt-5.5 · confidence 86%